| Year |
Citation |
Score |
| 2009 |
Constantin T, Kálovics T, Ponyi A, Nagy E, Sallai K, Szabó L, Garami M, Müller J, Gergely P, Dankó K, Fekete G, Kálmánchey R. Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 15: CR164-9. PMID 19333200 |
0.509 |
|
| 2009 |
Kohut E, Hajdu M, Gergely P, Gopcsa L, Kilián K, Pálóczi K, Kopper L, Sebestyén A. Expression of TGFbeta1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus. Pathology Oncology Research : Por. 15: 251-6. PMID 19020994 DOI: 10.1007/S12253-008-9119-8 |
0.336 |
|
| 2005 |
Gergely P, Pullmann R, Stancato C, Otvos L, Koncz A, Blazsek A, Poor G, Brown KE, Phillips PE, Perl A. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). 116: 124-34. PMID 15894513 DOI: 10.1016/J.Clim.2005.04.002 |
0.31 |
|
| 2005 |
Sallai K, Nagy E, Derfalvy B, Müzes G, Gergely P. Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus. Clinical and Diagnostic Laboratory Immunology. 12: 56-9. PMID 15642985 DOI: 10.1128/Cdli.12.1.56-59.2005 |
0.357 |
|
| 2004 |
Perl A, Nagy G, Gergely P, Puskas F, Qian Y, Banki K. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods in Molecular Medicine. 102: 87-114. PMID 15286382 DOI: 10.1385/1-59259-805-6:087 |
0.337 |
|
| 2004 |
Perl A, Gergely P, Nagy G, Koncz A, Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends in Immunology. 25: 360-7. PMID 15207503 DOI: 10.1016/J.It.2004.05.001 |
0.368 |
|
| 2003 |
Hidvégi B, Nagy E, Szabó T, Temesvári E, Marschalkó M, Kárpáti S, Horváth A, Gergely P. Correlation between T-cell and mast cell activity in patients with chronic urticaria. International Archives of Allergy and Immunology. 132: 177-82. PMID 14600430 DOI: 10.1159/000073719 |
0.337 |
|
| 2002 |
Perl A, Gergely P, Puskas F, Banki K. Metabolic switches of T-cell activation and apoptosis. Antioxidants & Redox Signaling. 4: 427-43. PMID 12215210 DOI: 10.1089/15230860260196227 |
0.341 |
|
| 2002 |
Puskas F, Gergely P, Niland B, Banki K, Perl A. Differential regulation of hydrogen peroxide and Fas-dependent apoptosis pathways by dehydroascorbate, the oxidized form of vitamin C. Antioxidants & Redox Signaling. 4: 357-69. PMID 12215204 DOI: 10.1089/15230860260196164 |
0.332 |
|
| 2002 |
Gergely P, Niland B, Gonchoroff N, Pullmann R, Phillips PE, Perl A. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 169: 1092-101. PMID 12097418 DOI: 10.4049/Jimmunol.169.2.1092 |
0.338 |
|
| 2002 |
Gergely P, Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 46: 175-90. PMID 11817589 DOI: 10.1002/1529-0131(200201)46:1<175::Aid-Art10015>3.0.Co;2-H |
0.373 |
|
| 2001 |
Nagy G, Horváth A, Füst G, Romics L, Gergely P, Karádi I. Anticholesterol antibody levels in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 60: 722-3. PMID 11436863 DOI: 10.1136/Ard.60.7.722 |
0.329 |
|
| 2001 |
Nagy G, Pállinger E, Antal-Szalmás P, Aleksza M, Marschalkó M, Brózik M, Falus A, Gergely P. Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus. Immunology Letters. 74: 207-10. PMID 11064102 DOI: 10.1016/S0165-2478(00)00265-0 |
0.328 |
|
| 2000 |
Csiszár A, Nagy G, Gergely P, Pozsonyi T, Pócsik É. Increased interferon-gamma (IFN-γ), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) Clinical and Experimental Immunology. 122: 464-470. PMID 11122256 DOI: 10.1046/J.1365-2249.2000.01369.X |
0.315 |
|
| 2000 |
Nagy G, Brózik M, Varga L, Füst G, Kirschfink M, Kiss E, Gergely P. Usefulness of detection of complement activation products in evaluating SLE activity. Lupus. 9: 19-25. PMID 10713643 DOI: 10.1177/096120330000900105 |
0.301 |
|
| 1998 |
Nagy E, Szakonyi J, Gergely P. Imuthiol inhibits the etoposide-induced apoptosis in HL-60 cells Immunology Letters. 64: 1-4. PMID 9865594 DOI: 10.1016/S0165-2478(98)00075-3 |
0.329 |
|
| 1990 |
Perl A, DiVincenzo JP, Ryan DH, Gergely P, Szigeti A, Feher J, Abraham GN. Rearrangement of the T-cell receptor alpha, beta and gamma chain genes in chronic lymphocytic leukemia. Leukemia Research. 14: 131-7. PMID 2156113 DOI: 10.1016/0145-2126(90)90041-7 |
0.309 |
|
| 1989 |
Phi NC, Takáts, Binh VH, Vien CV, González-Cabello, Gergely P. Cyclic AMP level of lymphocytes in patients with systemic lupus erythematosus and its relation to disease activity Immunology Letters. 23: 61-64. PMID 2558072 DOI: 10.1016/0165-2478(89)90156-9 |
0.366 |
|
| 1987 |
Láng I, Nékám K, Deák G, Müzes G, Gonzalez CR, Kádár J, Perl A, Gergely P, Fehér J. Effect of (+)cyanidanol-3 on cellular immune reactions and on superoxide dismutase activity in vitro. Free Radical Research. 4: 51-60. PMID 2976388 DOI: 10.3109/10715768709088088 |
0.398 |
|
| 1986 |
Perl A, Láng I, Gonzalez-Cabello R, Filep J, Nékám K, Gergely P, Fehér J. Indomethacin abrogates the suppression by cyclosporin A of lectin-dependent cell-mediated cytotoxicity to HEp-2 cells. Immunopharmacology. 11: 39-45. PMID 3957649 DOI: 10.1016/0162-3109(86)90063-9 |
0.348 |
|
| 1984 |
Kalmar L, Gyires K, Gergely P. Inhibitory effect of tumour cells on leukocyte motility Immunology Letters. 8: 175-177. PMID 6500634 DOI: 10.1016/0165-2478(84)90073-7 |
0.308 |
|
| 1984 |
Perl A, Gonzalez-Cabello R, Láng I, Gergely P. Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells Cellular Immunology. 84: 185-193. PMID 6230158 DOI: 10.1016/0008-8749(84)90089-3 |
0.334 |
|
| 1984 |
Gergely P, Nékam K, Láng I, Kalmár L, González-Cabello R, Perl A. Ketoconazole in vitro inhibits mitogen-induced blastogenesis, antibody-dependent cellular cytotoxicity, natural killer activity and random migration of human leukocytes. Immunopharmacology. 7: 167-170. PMID 6088429 DOI: 10.1016/0162-3109(84)90033-X |
0.34 |
|
| 1983 |
Perl A, Gonzalez-Cabello R, Láng I, Somos P, Gergely P. Depressed lectin-dependent cell-mediated cytotoxicity against adherent HEP-2 cells in patients with carcinoma of the uterine cervix Cancer Immunology, Immunotherapy. 15: 155-158. PMID 6553513 DOI: 10.1007/Bf00199708 |
0.334 |
|
| 1983 |
Pócsik E, González-Cabello R, Gergely P. Precultured and fresh human T-cells suppress the mitogen response of autologous lymphocytes Immunology Letters. 6: 97-100. PMID 6221996 DOI: 10.1016/0165-2478(83)90088-3 |
0.319 |
|
| 1983 |
Perl A, Gonzalez-Cabello R, Pócsik É, Láng I, Gergely P. Effect of Fc receptor blocking on human natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells. Immunology Letters. 6: 317-321. PMID 6195101 DOI: 10.1016/0165-2478(83)90074-3 |
0.354 |
|
| 1982 |
Láng I, Nékám K, Gergely P, Petrányi G. Effect of in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity Clinical Immunology and Immunopathology. 25: 139-144. PMID 7151336 DOI: 10.1016/0090-1229(82)90173-8 |
0.351 |
|
| 1982 |
Kalmár L, Gergely P. Enhancement of mitogen-induced lymphocyte proliferation after preincubation is due to altered sensitivity to prostaglandins. Immunology Letters. 4: 179-183. PMID 6284639 DOI: 10.1016/0165-2478(82)90010-4 |
0.312 |
|
| 1981 |
Láng I, Török K, Gergely P, Nékám K, Petrányi G. Effect of Histamine Receptor Blocking on Human Antibody‐dependent Cell‐mediated Cytotoxicity Scandinavian Journal of Immunology. 13: 361-366. PMID 6117941 DOI: 10.1111/J.1365-3083.1981.Tb00145.X |
0.32 |
|
| 1979 |
Nékám K, Láng I, Török K, Kalmár L, Gergely P, Petrányi G. Effects of therapy with dialyzable leukocyte extracts containing transfer factor activity on antibody-dependent cytotoxic activity in humans. Clinical Immunology and Immunopathology. 13: 407-412. PMID 226302 DOI: 10.1016/0090-1229(79)90082-5 |
0.373 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2010 |
Mészáros T, Füst G, Farkas H, Jakab L, Temesszentandrási G, Nagy G, Kiss E, Gergely P, Zeher M, Griger Z, Czirják L, Hóbor R, Haris A, Polner K, Varga L. C1-inhibitor autoantibodies in SLE. Lupus. 19: 634-638. PMID 20071476 DOI: 10.1177/0961203309357059 |
0.298 |
|
| 1991 |
Kádár J, Sármay G, Rajnavölgyi É, Stanworth D, Gergely P. Modulatory effect of synthetic human IgG Fc peptides on the in vitro immune response of murine spleen cells. International Journal of Immunopharmacology. 13: 1147-1155. PMID 1814851 DOI: 10.1016/0192-0561(91)90166-5 |
0.297 |
|
| 2007 |
Jakab L, Laki J, Sallai K, Temesszentandrási G, Pozsonyi T, Kalabay L, Varga L, Gombos T, Blaskó B, Bíró A, Madsen HO, Radics J, Gergely P, Füst G, Czirják L, et al. Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clinical Immunology (Orlando, Fla.). 125: 230-6. PMID 17942372 DOI: 10.1016/J.Clim.2007.08.020 |
0.296 |
|
| 2001 |
Brozik M, Szakonyi J, Magyar A, Tóbi R, Rojkovich B, Hudecz F, Gergely P. Investigation of the epitopes of human profilaggrin derived peptide targeted by antibodies of patient with rheumatoid arthritis Arthritis Research & Therapy. 3: 8. DOI: 10.1186/Ar177 |
0.292 |
|
| 1992 |
Kádár J, Kalmár L, Stanworth DR, Gergely P. Synthetic peptides comprising defined sequences of CH-2 and CH-3 domains of human IgG1 induce prostaglandin E2 production from human peripheral blood mononuclear cells Immunology Letters. 32: 59-63. PMID 1500084 DOI: 10.1016/0165-2478(92)90199-X |
0.292 |
|
| 1994 |
Blázovics A, González-Cabello R, Barta I, Gergely P, Fehér J, Kéry Å, Petri G. Effect of liver-protecting Sempervivum tectorum extract on the immune reactivity of spleen cells in hyperlipidaemic rats Phytotherapy Research. 8: 33-37. DOI: 10.1002/Ptr.2650080108 |
0.291 |
|
| 2008 |
Perl A, Nagy G, Koncz A, Gergely P, Fernandez D, Doherty E, Telarico T, Bonilla E, Phillips PE. Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity. 41: 287-97. PMID 18432409 DOI: 10.1080/08916930802024764 |
0.291 |
|
| 2000 |
Puskas F, Gergely P, Banki K, Perl A. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C The Faseb Journal. 14: 1352-1361. DOI: 10.1096/Fasebj.14.10.1352 |
0.29 |
|
| 1983 |
Kalmár L, Gergely P. Effect of prostaglandins on polymorphonuclear leukocyte motolity Immunopharmacology. 6: 167-175. PMID 6579044 DOI: 10.1016/0162-3109(83)90018-8 |
0.29 |
|
| 2006 |
Nagy G, Ward J, Mosser DD, Koncz A, Gergely P, Stancato C, Qian Y, Fernandez D, Niland B, Grossman CE, Telarico T, Banki K, Perl A. Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection. The Journal of Biological Chemistry. 281: 34574-91. PMID 16935861 DOI: 10.1074/Jbc.M606301200 |
0.289 |
|
| 2000 |
Nagy E, Mihalik R, Hrabák A, Vértesi C, Gergely P. Apoptosis inhibitory effect of the isothiourea compound, tri-(2-thioureido-S-ethyl)-amine. Immunopharmacology. 47: 25-33. PMID 10708807 DOI: 10.1016/S0162-3109(99)00183-6 |
0.286 |
|
| 2008 |
Isaák A, Gergely P, Szekeres Z, Prechl J, Poór G, Erdei A, Gergely J. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients. International Immunology. 20: 185-92. PMID 18182380 DOI: 10.1093/Intimm/Dxm132 |
0.286 |
|
| 1990 |
Kalmár L, Kádár J, Somogyi A, Gergely P, Csomós G, Fehér J. Silibinin (Legalon-70) enhances the motility of human neutrophils immobilized by formyl-tripeptide, calcium ionophore, lymphokine and by normal human serum. Agents and Actions. 29: 239-46. PMID 2111081 DOI: 10.1007/Bf01966453 |
0.286 |
|
| 1985 |
Perl A, Gonzalez-Cabello R, Falucskai L, Gergely P, Fehér J. Contrasting effects of RNA and protein synthesis blocking on natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells. Cellular and Molecular Life Sciences. 41: 1344-1346. PMID 2412880 DOI: 10.1007/Bf01952087 |
0.284 |
|
| 2001 |
Horváth MÉ, González-Cabello R, Blázovics A, Looij Mvd, Barta I, Müzes G, Gergely P, Fehér J. Effect of silibinin and vitamin E on restoration of cellular immune response after partial hepatectomy Journal of Ethnopharmacology. 77: 227-232. PMID 11535368 DOI: 10.1016/S0378-8741(01)00298-7 |
0.281 |
|
| 2004 |
Erdei A, Prechl J, Isaák A, Józsi M, Bajtay Z, Molnár E, Gergely P, Poór G, Gergely J. Regulation of B-cell activation by complement receptors CR1 (CD35) and CR2 (CD21)—possible involvement in the pathogenesis of autoimmune diseases Autoimmunity Reviews. 3: 624-625. DOI: 10.1016/J.Autrev.2004.08.001 |
0.277 |
|
| 2007 |
Sallai KK, Nagy E, Bodó I, Mohl A, Gergely P. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. Scandinavian Journal of Rheumatology. 36: 198-205. PMID 17657674 DOI: 10.1080/03009740601089283 |
0.277 |
|
| 1992 |
Gergely P, González-Cabello R, Müzes G, Körmöczy PS, Kulics J. In vitro effects of theophylline on human lymphocyte and monocyte functions Pharmacological Research. 25: 306-307. DOI: 10.1016/1043-6618(92)90418-B |
0.276 |
|
| 1999 |
Gergely P. Drug-induced lymphopenia: focus on CD4+ and CD8+ cells. Drug Safety. 21: 91-100. PMID 10456378 DOI: 10.2165/00002018-199921020-00003 |
0.275 |
|
| 2003 |
Brózik M, Szakonyi J, Magyar A, Rojkovich B, Tobi R, Hudecz F, Gergely P, Merétey K. Investigation of the reactivity patterns of antifilaggrin antibodies in sera and synovial fluids from patients with rheumatoid arthritis using citrullinated synthetic peptides Arthritis Research & Therapy. 5: 2-2. DOI: 10.1186/Ar632 |
0.272 |
|
| 1999 |
Rojkovich B, Nagy E, Pröhle T, Poór G, Gergely P. Urinary Excretion of Thiol Compounds in Patients with Rheumatoid Arthritis Clinical and Vaccine Immunology. 6: 683-685. DOI: 10.1128/Cdli.6.5.683-685.1999 |
0.27 |
|
| 2007 |
Bodolay E, Dérfalvi B, Gergely P, Poór G. [When does an autoimmune disease begin? Importance of the early diagnosis]. Orvosi Hetilap. 148: 25-30. PMID 17430790 DOI: 10.1556/Oh.2007.28031 |
0.268 |
|
| 2006 |
Gergely P, Perl A, Poór G. Possible pathogenic nature of the recently discovered TT virus: does it play a role in autoimmune rheumatic diseases? Autoimmunity Reviews. 6: 5-9. PMID 17110309 DOI: 10.1016/J.Autrev.2006.03.002 |
0.266 |
|
| 1996 |
Gergely P, Vértesi C. Urinary Excretion of Thioamine Compounds in Patients with Malignant Tumors and Inflammation. Pathology Oncology Research : Por. 2: 167-170. PMID 11173600 DOI: 10.1007/Bf02903520 |
0.265 |
|
| 2001 |
Hidvégi B, González-Cabello R, Temesvári E, Szentmihályi A, Nagy E, Fekete B, Marschalkó M, Horváth A, Gergely P. The effect of heat-inactivated Helicobacter pylori on the blastogenic response of peripheral blood mononuclear cells of patients with chronic urticaria. International Archives of Allergy and Immunology. 126: 167-172. PMID 11729355 DOI: 10.1159/000049508 |
0.262 |
|
| 2007 |
Gergely P, Fekete B. [New possibilities of treating patients with autoimmune disorders]. Orvosi Hetilap. 148: 58-62. PMID 17430796 DOI: 10.1556/Oh.2007.28037 |
0.256 |
|
| 2008 |
Müzes G, Deák G, Láng I, González‐Cabello R, Gergely P, Fehér J. Depressed monocyte production of interleukin-1 and tumor necrosis factor-alpha in patients with alcoholic liver cirrhosis. Liver. 9: 302-306. PMID 2586242 DOI: 10.1111/J.1600-0676.1989.Tb00415.X |
0.256 |
|
| 1984 |
Gergely P. Severe neutropenia in systemic lupus erythematosus Arthritis & Rheumatism. 27: 719-719. PMID 6732890 DOI: 10.1002/Art.1780270623 |
0.253 |
|
| 1992 |
Gergely P, Falus A, Vertesi C, Körmöczy PS. In vitro immunomodulatory effects of imuthiol Pharmacological Research. 25: 304-305. DOI: 10.1016/1043-6618(92)90417-A |
0.251 |
|
| 2011 |
Farkas H, Csuka D, Gács J, Czaller I, Zotter Z, Füst G, Varga L, Gergely P. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency. Clinical Immunology (Orlando, Fla.). 141: 58-66. PMID 21636327 DOI: 10.1016/J.Clim.2011.05.004 |
0.248 |
|
| 2004 |
Perl A, Gergely P, Banki K. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. International Reviews of Immunology. 23: 293-313. PMID 15204090 DOI: 10.1080/08830180490452576 |
0.248 |
|
| 1992 |
Gergely P. The pathogenesis of autoimmune disease. Immunology Today. 13. PMID 1510805 DOI: 10.1016/0167-5699(92)90062-C |
0.246 |
|
| 1982 |
Kalmar L, Ablonczy E, Müzes GY, Gergely P, Neumark T. Coexistence of systemic lupus eruthematosus and gout Arthritis & Rheumatism. 25: 1505-1506. PMID 7150386 DOI: 10.1002/Art.1780251222 |
0.243 |
|
| 2010 |
Pazár B, Sáfrány E, Gergely P, Szántó S, Szekanecz Z, Poór G. Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: the rs27044 variant is associated with HLA-B*2705 subtype in Hungarian patients with ankylosing spondylitis. The Journal of Rheumatology. 37: 379-84. PMID 20032103 DOI: 10.3899/Jrheum.090806 |
0.233 |
|
| 1997 |
Murányi A, Gergely P, Nagy GM, Fekete MI. The possible role of protein phosphatase 2A in the sodium sensitivity of the receptor binding of opiate antagonists naloxone and naltrindole. Brain Research Bulletin. 44: 273-9. PMID 9323442 DOI: 10.1016/S0361-9230(97)00136-6 |
0.231 |
|
| 2000 |
Thorell S, Gergely P, Banki K, Perl A, Schneider G. The three-dimensional structure of human transaldolase. Febs Letters. 475: 205-208. PMID 10869557 DOI: 10.1016/S0014-5793(00)01658-6 |
0.219 |
|
| 2023 |
Hawtin S, André C, Collignon-Zipfel G, Appenzeller S, Bannert B, Baumgartner L, Beck D, Betschart C, Boulay T, Brunner HI, Ceci M, Deane J, Feifel R, Ferrero E, Kyburz D, ... ... Gergely P, et al. Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy. Cell Reports. Medicine. 4: 101036. PMID 37196635 DOI: 10.1016/j.xcrm.2023.101036 |
0.209 |
|
| 1992 |
Vértesi C, Szende B, Gergely P, Körmöczy PS. S-allylgutimine has immunostimulatory and antitumor effects Pharmacological Research. 25: 321-322. DOI: 10.1016/1043-6618(92)90426-C |
0.204 |
|
| 2010 |
Bazsó A, Poór G, Gergely P, Kiss E. [Novel therapeutic possibilities in systemic lupus erythematosus]. Orvosi Hetilap. 151: 735-40. PMID 20410000 DOI: 10.1556/OH.2010.28863 |
0.203 |
|
| 2003 |
Kiss C, Poór G, Donáth J, Gergely P, Paksy A, Zajkás G, Antal M. Prevalence of obesity in an elderly Hungarian population. European Journal of Epidemiology. 18: 653-7. PMID 12952138 DOI: 10.1023/A:1024994507436 |
0.199 |
|
| 2008 |
Blazsek A, Sillo P, Ishii N, Gergely P, Poor G, Preisz K, Hashimoto T, Medvecz M, Kárpáti S. Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoid. Experimental Dermatology. 17: 446-54. PMID 18400063 DOI: 10.1111/J.1600-0625.2007.00663.X |
0.194 |
|
| 2020 |
Nagy E, Komlósi ZI, Márton DF, Halász A, Gergely P, Somogyi A. True insulin allergy? Lessons from a case of suspected insulin allergy Orvosi Hetilap. 161: 1483-1487. PMID 32822327 DOI: 10.1556/650.2020.31900 |
0.191 |
|
| 2020 |
Fisher BA, Szanto A, Ng WF, Bombardieri M, Posch MG, Papas AS, Farag AM, Daikeler T, Bannert B, Kyburz D, Kivitz AJ, Carsons SE, Isenberg DA, Barone F, Bowman SJ, ... ... Gergely P, et al. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. The Lancet. Rheumatology. 2: e142-e152. PMID 38263652 DOI: 10.1016/S2665-9913(19)30135-3 |
0.183 |
|
| 2007 |
Gergely P, Isaák A, Szekeres Z, Prechl J, Erdei A, Nagy ZB, Gergely J, Poór G. Altered expression of Fcgamma and complement receptors on B cells in systemic lupus erythematosus. Annals of the New York Academy of Sciences. 1108: 183-92. PMID 17893984 |
0.177 |
|
| 2005 |
Gergely P, Blazsek A, Dankó K, Ponyi A, Poór G. Detection of TT virus in patients with idiopathic inflammatory myopathies. Annals of the New York Academy of Sciences. 1050: 304-13. PMID 16014546 DOI: 10.1196/annals.1313.032 |
0.175 |
|
| 2019 |
Espié P, He Y, Koo P, Sickert D, Dupuy C, Chokoté E, Schuler R, Mergentaler H, Ristov J, Milojevic J, Verles A, Groenewegen A, Auger A, Avrameas A, Rotte M, ... ... Gergely P, et al. First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety and tolerability of iscalimab, an anti-CD40 monoclonal antibody. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 31647605 DOI: 10.1111/ajt.15661 |
0.169 |
|
| 2019 |
Kahaly GJ, Stan MN, Frommer L, Gergely P, Colin L, Amer A, Schuhmann I, Espie P, Rush JS, Basson C, He YL. A Novel Anti-Cd40 Monoclonal Antibody, Iscalimab, for Control of Graves' Hyperthyroidism - A Proof-Of-Concept Trial. The Journal of Clinical Endocrinology and Metabolism. PMID 31512728 DOI: 10.1210/clinem/dgz013 |
0.161 |
|
| 2022 |
Dertschnig S, Gergely P, Finke J, Schanz U, Holler E, Holtick U, Socié G, Medinger M, Passweg J, Teshima T, Stylianou C, Oehen S, Heim D, Bucher C. Mocravimod, a selective S1PR modulator in allogeneic hematopoietic stem cell transplantation for malignancy. Transplantation and Cellular Therapy. PMID 36343893 DOI: 10.1016/j.jtct.2022.10.029 |
0.156 |
|
| 2023 |
GomezMancilla B, Meriggioli MN, Genge A, Roubenoff R, Espié P, Dupuy C, Hartmann N, Pezous N, Kinhikar A, Tichy M, Dionne A, Vissing J, Andersen H, Schoser B, Meisel A, ... ... Gergely P, et al. Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 119: 76-84. PMID 37988976 DOI: 10.1016/j.jocn.2023.11.013 |
0.145 |
|
| 2007 |
Poór G, Nagy ZB, Schmidt Z, Brózik M, Merétey K, Gergely P. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis. Annals of the New York Academy of Sciences. 1110: 23-32. PMID 17911417 DOI: 10.1196/annals.1423.004 |
0.142 |
|
| 2020 |
Radeke HH, Stein J, Van Assche G, Rogler G, Lakatos PL, Muellershausen F, Moulin P, Jarvis P, Colin L, Gergely P, Kruis W. A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis. Inflammatory Intestinal Diseases. 5: 180-190. PMID 33313070 DOI: 10.1159/000509393 |
0.141 |
|
| 2017 |
Smith P, O'Sullivan C, Gergely P. Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic Hematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences. 18. PMID 28934113 DOI: 10.3390/ijms18102027 |
0.138 |
|
| 2023 |
Combi Z, Potor L, Nagy P, Sikura KÉ, Ditrói T, Jurányi EP, Galambos K, Szerafin T, Gergely P, Whiteman M, Torregrossa R, Ding Y, Beke L, Hendrik Z, Méhes G, et al. Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of HS lead to HS deficiency in calcific aortic valve disease. Redox Biology. 60: 102629. PMID 36780769 DOI: 10.1016/j.redox.2023.102629 |
0.126 |
|
| 2024 |
Rácz K, Simon G, Kurucz A, Harsányi GT, Török M, Herczeg LT, Gergely PA. Case Report: A Sudden Thyroid-Related Death of a 15-Year-Old Girl. Diagnostics (Basel, Switzerland). 14. PMID 38732319 DOI: 10.3390/diagnostics14090905 |
0.12 |
|
| 2017 |
Chen CW, Beyer C, Liu J, Maier C, Li C, Trinh-Minh T, Xu X, Cole SH, Hsieh MH, Ng N, Althage A, Meeusen S, Pan S, Svensson EC, Seidel HM, ... ... Gergely P, et al. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling. Annals of the Rheumatic Diseases. PMID 28153829 DOI: 10.1136/Annrheumdis-2016-210294 |
0.119 |
|
| 2023 |
Shisha T, Posch MG, Lehmann J, Feifel R, Junt T, Hawtin S, Schuemann J, Avrameas A, Danekula R, Misiolek P, Siegel R, Gergely P. First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults. European Journal of Drug Metabolism and Pharmacokinetics. PMID 37532923 DOI: 10.1007/s13318-023-00847-3 |
0.109 |
|
| 2022 |
Nishimura JI, Ando K, Masuko M, Noji H, Ito Y, Mayer J, Griskevicius L, Bucher C, Müllershausen F, Gergely P, Rozenberg I, Schubart A, Chawla R, Rondeau JM, Roguska M, et al. Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria. Haematologica. PMID 35263983 DOI: 10.3324/haematol.2020.265868 |
0.102 |
|
| 2006 |
Kiss C, Jónap I, Gergely P, Poór G. Coexistent Marfan's syndrome and ankylosing spondylitis. The Journal of Rheumatology. 33: 1199-200. PMID 16755670 |
0.098 |
|
| 2004 |
Gergely P, Poór G. Relapsing polychondritis. Best Practice & Research. Clinical Rheumatology. 18: 723-38. PMID 15454129 DOI: 10.1016/j.berh.2004.05.012 |
0.098 |
|
| 2007 |
Gergely P, Poór G. [New ways in the management of rheumatoid arthritis in Hungary]. Lege Artis Medicinae : ÚJ Magyar Orvosi HíRmondó. 17: 657-64. PMID 19227595 |
0.096 |
|
| 2021 |
Balla J, Potor L, Hendrik Z, Patsalos A, Katona É, Méhes G, Póliska S, Csősz É, Kalló G, Komáromi I, Combi Z, Posta N, Sikura KÉ, Pethő D, Oros M, ... ... Gergely P, et al. OXIDATION OF HEMOGLOBIN DRIVES A PRO-ATHEROGENIC POLARIZATION OF MACROPHAGES IN HUMAN ATHEROSCLEROSIS. Antioxidants & Redox Signaling. PMID 34269613 DOI: 10.1089/ars.2020.8234 |
0.094 |
|
| 2008 |
Nagy ZB, Gergely P, Donáth J, Borgulya G, Csanád M, Poór G. Gene expression profiling in Paget's disease of bone: upregulation of interferon signaling pathways in pagetic monocytes and lymphocytes. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 23: 253-9. PMID 18197754 DOI: 10.1359/jbmr.071021 |
0.085 |
|
| 2018 |
Bencze J, Pocsai K, Murnyák B, Gergely PA, Juhász B, Szilvássy Z, Hortobágyi T. The Melanin-concentrating Hormone System in Human, Rodent and Avian Brain. Open Medicine (Warsaw, Poland). 13: 264-269. PMID 29992190 DOI: 10.1515/med-2018-0040 |
0.085 |
|
| 2014 |
Mócsai A, Kovács L, Gergely P. What is the future of targeted therapy in rheumatology: biologics or small molecules? Bmc Medicine. 12: 43. PMID 24620738 DOI: 10.1186/1741-7015-12-43 |
0.084 |
|
| 2019 |
Gergely PA, Murnyák B, Bencze J, Kurucz A, Varjas T, Gombos K, Hortobágyi T. Tyrosine Kinase Inhibitor Imatinib Mesylate Alters DMBA-Induced Early Onco/Suppressor Gene Expression with Tissue-Specificity in Mice. Biomed Research International. 2019: 8670398. PMID 30882001 DOI: 10.1155/2019/8670398 |
0.079 |
|
| 2002 |
Gergely P. [The role of focal infections in the pathogenesis of diseases]. Orvosi Hetilap. 143: 1749-53. PMID 12198923 |
0.072 |
|
| 2009 |
Gergely P, Pazár B, Nagy ZB, Gombos T, Rajczy K, Balogh Z, Orbán I, Sevcic K, Poór G. Structural polymorphisms in the mannose-binding lectin gene are associated with juvenile idiopathic arthritis. The Journal of Rheumatology. 36: 843-7. PMID 19286845 DOI: 10.3899/jrheum.080681 |
0.071 |
|
| 2012 |
Hrabovszky E, Sipos MT, Molnár CS, Ciofi P, Borsay BÁ, Gergely P, Herczeg L, Bloom SR, Ghatei MA, Dhillo WS, Liposits Z. Low degree of overlap between kisspeptin, neurokinin B, and dynorphin immunoreactivities in the infundibular nucleus of young male human subjects challenges the KNDy neuron concept. Endocrinology. 153: 4978-89. PMID 22903610 DOI: 10.1210/en.2012-1545 |
0.068 |
|
| 2013 |
Hrabovszky E, Molnár CS, Borsay BÁ, Gergely P, Herczeg L, Liposits Z. Orexinergic input to dopaminergic neurons of the human ventral tegmental area. Plos One. 8: e83029. PMID 24376626 DOI: 10.1371/journal.pone.0083029 |
0.053 |
|
| 2023 |
Dörner T, Kaul M, Szántó A, Tseng JC, Papas AS, Pylvaenaeinen I, Hanser M, Abdallah N, Grioni A, Santos Da Costa A, Ferrero E, Gergely P, Hillenbrand R, Avrameas A, Cenni B, et al. Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial. Annals of the Rheumatic Diseases. PMID 37932009 DOI: 10.1136/ard-2023-224691 |
0.052 |
|
| 2022 |
Seror R, Baron G, Camus M, Cornec D, Perrodeau E, Bowman SJ, Bombardieri M, Bootsma H, Gottenberg JE, Fisher B, Hueber W, van Roon JA, Devauchelle-Pensec V, Gergely P, Mariette X, et al. Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. PMID 35393271 DOI: 10.1136/annrheumdis-2021-222054 |
0.048 |
|
| 2021 |
Éva Sikura K, Combi Z, Potor L, Szerafin T, Hendrik Z, Méhes G, Gergely P, Whiteman M, Beke L, Fürtös I, Balla G, Balla J. Hydrogen sulfide inhibits aortic valve calcification in heart via regulating RUNX2 by NF-κB, a link between inflammation and mineralization. Journal of Advanced Research. 27: 165-176. PMID 33318875 DOI: 10.1016/j.jare.2020.07.005 |
0.043 |
|
| 2007 |
Varga-Orvos Z, Nagy ZB, Mészáros A, Kökény S, Gergely P, Tamás L, Poór G. Multiplex site-directed mutagenesis strategy including high-efficiency selection of the mutant PCR products. Biotechnology Letters. 29: 1921-5. PMID 17687622 DOI: 10.1007/s10529-007-9474-7 |
0.04 |
|
| 2023 |
Halasi BD, Borsay BÁ, Pórszász RK, Gergely PA. Lethal threat in the use of glass doors at home: A case report. Legal Medicine (Tokyo, Japan). 66: 102365. PMID 38041907 DOI: 10.1016/j.legalmed.2023.102365 |
0.039 |
|
| 2011 |
Budán F, Szabó I, Varjas T, Nowrasteh G, Dávid T, Gergely P, Varga Z, Molnár K, Kádár B, Orsós Z, Kiss I, Ember I. Mixtures of Uncaria and Tabebuia extracts are potentially chemopreventive in CBA/Ca mice: a long-term experiment. Phytotherapy Research : Ptr. 25: 493-500. PMID 20799345 DOI: 10.1002/ptr.3281 |
0.011 |
|
| 2018 |
Bán Á, Patonai Z, Fogarasi K, Schneider P, Boda R, Gergely P. [Analysis of medical diagnostic reports (constats) on dental injuries from terminological, dental and forensic medical points of view]. Orvosi Hetilap. 159: 2154-2161. PMID 30556409 DOI: 10.1556/650.2018.31212 |
0.011 |
|
| Hide low-probability matches. |